Latest News

Grants in 2016

Congratulations to CTC research collaborators and CTC staff who have so far been awarded over $2 million in National Health and Medical Research Council (NHMRC) grants. The Minister for Health and... Read More

People at very high risk of melanoma would benefit from monitoring

Australia has one of the highest rates of melanoma in the world. A newly published study has shown that for people at very high risk, specialised surveillance clinics would cut costs and improve ... Read More

Career Achievement Award for John Simes

John Simes, director of CTC, has been honoured by an accolade from his colleagues in cancer research for his achievements over broad areas of leadership, advocacy, research, and teaching-the Cance... Read More

Published Research

A qualitative study of medical oncologists' experiences of their profession and workforce sustainability

PLoS ONE 2016; 11(11): e0166302

Broom A, Wong WK, Kirby E, Sibbritt D, Karikios D, Harrup R, Lwin Z

Chronic kidney disease

Lancet. Online 22 Nov 2016

Webster AC, Nagler EV, Morton RL, Masson P

Dieng M, Cust AE, Kasparian NA, Butow P, Costa DS, Menzies SW, Mann GJ, Morton RL

BMJ Open 2016; 6(10): e012153

Protocol for a within-trial economic evaluation of a psychoeducational intervention tailored to people at high risk of developing a second or subsequent melanoma

Antiplatelet therapy before or after 16 weeks gestation for preventing preeclampsia: an individual participant data meta-analysis

American Journal of Obstetrics and Gynecology. Online 5 Nov 2016

Meher S, Duley L, Hunter K, Askie L

See more publications

Upcoming Events

Careers at CTC


No Vacancies

TRIAL LOGIN
TRIALS DATA SYSTEMS
TRIAL RESULTS
STUDY WITH US
MAKE A DONATION